Details van artikel 118 van 177 gevonden artikelen
Liraglutide 3.0mg reduces body weight and improves cardiometabolic risk factors in adults with obesity or overweight, but without diabetes: The SCALE Obesity and Prediabetes randomised, double-blind, placebo-controlled 3-year trial
Titel:
Liraglutide 3.0mg reduces body weight and improves cardiometabolic risk factors in adults with obesity or overweight, but without diabetes: The SCALE Obesity and Prediabetes randomised, double-blind, placebo-controlled 3-year trial
Auteur:
Markovic, Tania Astrup, Arne Greenway, Frank Krempf, Michel Le Roux, Carel W. Vettor, Roberto Manning, Linda Shapiro Lilleøre, Søren K. Fujioka, Ken
Verschenen in:
Obesity research & clinical practice
Paginering:
Jaargang 13 (2019) nr. 1 pagina's 56-57
Jaar:
2019
Inhoud:
Uitgever:
Published by Elsevier B.V.
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 118 van 177 gevonden artikelen